Table 2.
Correlation of KRAS2 Mutation Status between Bile and Serum of Four Patients with Biliary Tract Carcinoma
Location | Bile | Serum | |
---|---|---|---|
Bil 15 | Extrahepatic | GAT (93.4%) | GAT (3.2%) |
GTT (1.2%) | GTT (4.3%) | ||
Bil 49 | Extrahepatic | AGT (<0.1%) | Wild type |
Bil 52 | Gallbladder | Wild type | GAT (1.2%) |
Bil 73 | Intrahepatic | GAT (3.5%) | GAT (1.0%) |
GTT (1.2%) |